Request for proposals to implement diagnostic connectivity for Cepheid GeneXpert devices in Ukraine
PATH's Challenge TB project works to decrease tuberculosis mortality and morbidity in high-burden countries, including Ukraine. In recent years, Ukraine has implemented 53 Cepheid GeneXpert devices for the molecular diagnosis of tuberculosis. While the devices are capable of producing electronic test information, they currently work standalone and are not connected. Results are mostly reported via paper-based systems using manual transcription, limiting the potential to maximize patient care and program management. PATH is seeking candidates to provide a connectivity solution consisting of hardware to allow the automatic transmission of diagnostic data from Cepheid GeneXpert devices to a server and software to read and interpret the data.
Interested and qualified parties are encouraged to review the RFP and submit propoals to firstname.lastname@example.org no later than March 8, 2017.
PATH Malaria Vaccine Initiative
Request for quote for drug product manufacture: fill/finish of monoclonal antibody
The PATH Malaria Vaccine Initiative works to accelerate the development of promising malaria vaccines and catalyze their availability and accessibility in the developing world. As part of this work, PATH is developing two human monoclonal antibodies for phase 1 clinical trials in the US and Europe. In each case, the manufacturing of drug substance has begun and is expected to be completed by January 2018. PATH is seeking a GMP contractor to fill these products, perform testing and stability studies, provide primary labeling and bulk packaging, and possibly provide frozen storage of the product, as detailed in the RFQ.
Interested and qualified parties are encouraged to review the RFQ and confirm their interest no later than February 20, 2017. Subsequent proposals are due by March 30, 2017.
All of our requests for proposals adhere to our principles for procurement operations.